Review on Ehrlich Ascites Carcinoma in Mice and Cancer Treatment with Special Reference to The Potential Protective and Therapeutic Effects of Hesperidin Versus Cisplatin
Last updated: 04 Jan 2025
10.21608/jcvr.2022.240866
Ehrlich Ascites Carcinoma, EAC, Chemotherapy, Cisplatin, Hesperidin
Nahed
Saleh
Department of Clinical Pathology, Faculty of Veterinary Medicine, University of Sadat City, Minufiya, Egypt.
nahed.thabet@vet.usc.edu.eg
Tamer
Allam
Department of Clinical Pathology, Faculty of Veterinary Medicine, University of Sadat City, Minufiya, Egypt.
tamer_sma@yahoo.com
Abdelfattah
Abdelfattah
Department of Clinical Pathology, Faculty of Veterinary Medicine, University of Sadat City, Minufiya, Egypt.
abdelfattah.mohamed@vet.usc.edu.eg
Sadat city
0000-0002-7424-8151
Nermeen
El-Borai
Department of Forensic Medicine & Toxicology, Faculty of veterinary medicine, University of Sadat City, Minufiya, Egypt.
nermeen.elborai@vet.usc.edu.eg
4
1
34447
2022-04-01
2022-02-04
2022-04-01
47
57
2636-4018
2636-4026
https://jcvr.journals.ekb.eg/article_240866.html
https://jcvr.journals.ekb.eg/service?article_code=240866
7
Original Article
799
Journal
Journal of Current Veterinary Research
https://jcvr.journals.ekb.eg/
Review on Ehrlich Ascites Carcinoma in Mice and Cancer Treatment with Special Reference to The Potential Protective and Therapeutic Effects of Hesperidin Versus Cisplatin
Details
Type
Article
Created At
22 Jan 2023